FLNA
Price
$0.65
Change
-$0.01 (-1.52%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
31.85M
20 days until earnings call
Intraday BUY SELL Signals
SPRB
Price
$46.06
Change
+$3.33 (+7.79%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
122.81M
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FLNA vs SPRB

FLNA vs SPRB Comparison Chart in %
View a ticker or compare two or three
VS
FLNA vs. SPRB commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLNA is a StrongBuy and SPRB is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for FLNA with price predictions
Oct 21, 2026

FLNA's Stochastic Oscillator is sitting in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +23.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where FLNA advanced for three days, in 191 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The 10-day RSI Indicator for FLNA moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 25 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FLNA as a result. In 78 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for FLNA turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 39 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

FLNA moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FLNA crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FLNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

FLNA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FLNA entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.501) is normal, around the industry mean (2.988). P/E Ratio (-0.758) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. FLNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FLNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SPRB with price predictions
Oct 21, 2026

SPRB in +5.77% Uptrend, rising for three consecutive days on October 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SPRB advanced for three days, in 202 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SPRB's RSI Indicator exited the oversold zone, 19 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 70 cases where SPRB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for SPRB just turned positive on October 21, 2026. Looking at past instances where SPRB's MACD turned positive, the stock continued to rise in 31 of 39 cases over the following month. The odds of a continued upward trend are 79%.

SPRB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

SPRB moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SPRB crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for SPRB entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.467) is normal, around the industry mean (2.988). P/E Ratio (-1.112) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (53.476) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. SPRB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
FLNA vs SPRB: Fundamental Ratings
FLNA
SPRB
OUTLOOK RATING
1..100
962
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
8481
P/E GROWTH RATING
1..100
1434
SEASONALITY SCORE
1..100
5024

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FLNA's Valuation (55) in the Pharmaceuticals Other industry is in the same range as SPRB (57) in the null industry. This means that FLNA’s stock grew similarly to SPRB’s over the last 12 months.

FLNA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SPRB (100) in the null industry. This means that FLNA’s stock grew similarly to SPRB’s over the last 12 months.

FLNA's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as SPRB (99) in the null industry. This means that FLNA’s stock grew similarly to SPRB’s over the last 12 months.

SPRB's Price Growth Rating (81) in the null industry is in the same range as FLNA (84) in the Pharmaceuticals Other industry. This means that SPRB’s stock grew similarly to FLNA’s over the last 12 months.

FLNA's P/E Growth Rating (14) in the Pharmaceuticals Other industry is in the same range as SPRB (34) in the null industry. This means that FLNA’s stock grew similarly to SPRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FLNASPRB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (FLNA: $0.66 vs. SPRB: $42.73)
Brand notoriety: FLNA and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FLNA: 11% vs. SPRB: 70%
Market capitalization -- FLNA: $31.85M vs. SPRB: $122.81M
FLNA [@Biotechnology] is valued at $31.85M. SPRB’s [@Biotechnology] market capitalization is $122.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.95B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FLNA’s FA Score shows that 1 FA rating(s) are green while SPRB’s FA Score has 0 green FA rating(s).

  • FLNA’s FA Score: 1 green, 4 red.
  • SPRB’s FA Score: 0 green, 5 red.
According to our system of comparison, both FLNA and SPRB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FLNA’s TA Score shows that 2 TA indicator(s) are bullish while SPRB’s TA Score has 5 bullish TA indicator(s).

  • FLNA’s TA Score: 2 bullish, 8 bearish.
  • SPRB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SPRB is a better buy in the short-term than FLNA.

Price Growth

FLNA (@Biotechnology) experienced а -9.88% price change this week, while SPRB (@Biotechnology) price change was +9.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.02%. For the same industry, the average monthly price growth was -18.10%, and the average quarterly price growth was -15.28%.

Reported Earning Dates

FLNA is expected to report earnings on Nov 11, 2026.

SPRB is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-1.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
FLNA
Daily Signal:
Gain/Loss:
SPRB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

FLNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLNA has been loosely correlated with ALT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FLNA jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLNA
1D Price
Change %
FLNA100%
-4.24%
ALT - FLNA
44%
Loosely correlated
-3.04%
JAGX - FLNA
43%
Loosely correlated
-13.31%
EDIT - FLNA
41%
Loosely correlated
-2.71%
VYGR - FLNA
41%
Loosely correlated
-7.76%
SANA - FLNA
40%
Loosely correlated
-0.42%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with IMRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then IMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
+3.64%
IMRX - SPRB
52%
Loosely correlated
+0.27%
MLEC - SPRB
51%
Loosely correlated
+3.75%
ANRO - SPRB
37%
Loosely correlated
-4.47%
FLNA - SPRB
36%
Loosely correlated
-4.24%
COYA - SPRB
36%
Loosely correlated
-1.66%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FIDU89.080.80
+0.91%
Fidelity MSCI Industrial Index ETF (FIDU)
SAUG27.090.04
+0.14%
FT Vest U.S. Small Cap Moderate Buffer ETF - August (SAUG)
NUSA22.70-0.01
-0.04%
Nuveen ESG 1-5 Year U.S. Aggregate Bond ETF (NUSA)
RISR37.40-0.15
-0.40%
FolioBeyond Alternative Income and Interest Rate Hedge ETF (RISR)
BIDG4.91-0.22
-4.31%
Leverage Shares 2X Long BIDU Daily ETF (BIDG)